Avalo Therapeutics, Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: 410-522-8707
CIK: 0001534120
EIN: 450705648
State Location: PA
State of Inc.: DE
Tickers:
  • Nasdaq:AVTX

Form: SCHEDULE 13G/A

Filing Date: 15 May 2026
Report Date:
Accepted: 15 May 2026 08:31 a.m.
Accession Number: 0001727492-26-000008
Act: 34
File Number: 005-89290
Film Number: 26983709

Documents

Primary Document
Accepted: 15 May 2026 08:31 a.m.